Perfect! Now I have good data. Let me create the article based on the analyst activity I found:

Biotech Draws Analyst Fire

APLS Apellis Pharmaceuticals topped analyst downgrade lists this week. The $5.2B biotech absorbed heavy downgrades despite surging 61% year to date. RSI hit 87 showing extreme overbought conditions.

CNTA Centessa Pharmaceuticals grabbed second place for analyst cuts. The $6.1B biotech gained 59% in 2026 yet saw fresh skepticism. Analysts trimmed targets as valuations stretched.

NKE Nike faced mounting pressure with analysts slashing forecasts. The athletic giant posted negative 4.5% return potential. Shares dropped 31% year to date as retail headwinds persisted. RSI sank to 20 signaling oversold territory.

IVN Ivanhoe Mines absorbed downgrades as metals volatility intensified. The $10.7B miner fell 33% this year facing 48% analyst upside potential. Short interest climbed with 30 days to cover.

Travel names showed massive analyst confidence. BKNG Booking Holdings held 3358% upside potential per consensus targets despite falling 22% year to date. TCOM Trip.com grabbed 939% upside as analysts backed Chinese travel recovery.

MSFT Microsoft drew 57% upside calls. The $2.8T software giant dropped 23% this year creating buying opportunities per Street views.